Novo Nordisk has launched Awiqli, the world's first once-weekly insulin, in India for adults with Type 1 and Type 2 diabetes. The treatment reduces insulin injections from 365 to just 52 a year. The company said it can reduce the fear of daily injections, improve treatment adherence and help patients manage diabetes more effectively.
Telangana
India Gets World's 1st Once-Weekly Insulin For Diabetes
